Home › Funds › Franklin International Growth Fund
Fund family: Franklin Global Trust · Filed by Franklin Global Trust (CIK 1124459) · SEC series S000022425
Share classes and tickers: FILRX (C000128792), FNGAX (C000064524), FNGDX (C000067641), FNGRX (C000067642), FNGZX (C000067643)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 561 with, 3 against, 0 abstentions (not counted as with management); 13 items carried no recommendation. Shareholder proposals: 2 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Franklin Global Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 281 | 0 |
| Corporate Governance | 90 | 1 |
| Compensation | 85 | 0 |
| Capital Structure | 66 | 0 |
| Audit-related | 39 | 0 |
| Extraordinary Transactions | 7 | 0 |
| Other | 3 | 0 |
| Other Social Issues | 3 | 1 |
| Say-on-Pay | 2 | 0 |
| Environment or Climate | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| argenx SE | November 18, 2025 | $37M | 1 | 0 |
| argenx SE | May 6, 2026 | $30M | 12 | 0 |
| MercadoLibre, Inc. | June 9, 2026 | $14M | 5 | 0 |
| Teva Pharmaceutical Industries Limited | May 28, 2026 | $9M | 3 | 0 |
| BioNTech SE | May 15, 2026 | $9M | 14 | 0 |
| NICE Ltd. (Israel) | September 30, 2025 | $5M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| July 24, 2025 | Macquarie Group Limited | Approve the Amendments to the Company's Constitution Shareholder proposal | Against | For |
| July 24, 2025 | Macquarie Group Limited | Approve the Climate Risk Exposure and Management Disclosures Shareholder proposal | Against | For |
| June 16, 2026 | Shopify Inc. | Adopt a Policy on Responsible Use of Artificial Intelligence ("AI") in the Company's Business and Operations Shareholder proposal | Against | For |
577 ballot items at 43 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Franklin International Growth Fund (FILRX) voted at 43 shareholder meetings of 38 companies, on 577 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 3 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 6 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.